Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.58/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.58), versus ($0.43) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy
• Truist upgrades Biogen to Buy on Alzheimer's, pipeline optimism ahead of key data